UCL-1608

N/A

Report date: 2025/02/05 13:46:27
NME

Base Information

Drug NameUCL-1608
Drug Alias Namecetiedil analogs (UCL)potassium channel blockers (UCL)UCL-1608
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionIntermediate conductance calcium-activated potassium channel protein 4 blockers
TargetsVoltage-gated potassium channel subunit Kv1.3Intermediate conductance calcium-activated potassium channel protein 4
Therapy Area/IndicationsAnemia, Sickle Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity College London
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity College London
Active IndicationsN/A
Inactive IndicationsAnemia, Sickle Cell

Other Information

ATC CodeN/A
Related LinksN/A